343 related articles for article (PubMed ID: 26372680)
21. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.
Tang H; Fang Z; Sun Y; Li B; Shi Z; Chen J; Zhang T; Xiu Q
Eur Respir J; 2010 Apr; 35(4):757-60. PubMed ID: 20356987
[TBL] [Abstract][Full Text] [Related]
22. A chitinase-like protein in the lung and circulation of patients with severe asthma.
Chupp GL; Lee CG; Jarjour N; Shim YM; Holm CT; He S; Dziura JD; Reed J; Coyle AJ; Kiener P; Cullen M; Grandsaigne M; Dombret MC; Aubier M; Pretolani M; Elias JA
N Engl J Med; 2007 Nov; 357(20):2016-27. PubMed ID: 18003958
[TBL] [Abstract][Full Text] [Related]
23. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
[TBL] [Abstract][Full Text] [Related]
24. YKL-40 protein is a marker of asthma.
Specjalski K; Jassem E
J Asthma; 2011 Oct; 48(8):767-72. PubMed ID: 21899483
[TBL] [Abstract][Full Text] [Related]
25. Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease.
Wu S; Hsu LA; Cheng ST; Teng MS; Yeh CH; Sun YC; Huang HL; Ko YL
Int J Mol Sci; 2014 Dec; 15(12):22421-37. PubMed ID: 25486056
[TBL] [Abstract][Full Text] [Related]
26. YKL-40 protein correlates with the phenotype of asthma.
Specjalski K; Chełmińska M; Jassem E
Lung; 2015 Apr; 193(2):189-94. PubMed ID: 25663327
[TBL] [Abstract][Full Text] [Related]
27. Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
Liu L; Zhang X; Liu Y; Zhang L; Zheng J; Wang J; Hansbro PM; Wang L; Wang G; Hsu AC
Respir Res; 2019 May; 20(1):95. PubMed ID: 31113430
[TBL] [Abstract][Full Text] [Related]
28. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
Ridker PM; Chasman DI; Rose L; Loscalzo J; Elias JA
J Am Heart Assoc; 2014 Jun; 3(3):e000897. PubMed ID: 24958781
[TBL] [Abstract][Full Text] [Related]
30. [Association between CHI3L1 SNPs and susceptibility to childhood asthma].
Li JM; Zhang HF; Shen XL; Xie H; Wu XD; Shen T; Wang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Feb; 17(2):144-8. PubMed ID: 25760838
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.
Sakazaki Y; Hoshino T; Takei S; Sawada M; Oda H; Takenaka S; Imaoka H; Matsunaga K; Ota T; Abe Y; Miki I; Fujimoto K; Kawayama T; Kato S; Aizawa H
PLoS One; 2011; 6(9):e24177. PubMed ID: 21915293
[TBL] [Abstract][Full Text] [Related]
32. Association of CHI3L1 in African-Americans with prior history of asthma exacerbations and stress.
Ortega H; Prazma C; Suruki RY; Li H; Anderson WH
J Asthma; 2013 Feb; 50(1):7-13. PubMed ID: 23190377
[TBL] [Abstract][Full Text] [Related]
33. The relationship between serum YKL-40 levels and severity of asthma.
Duru S; Yüce G; Ulasli SS; Erdem M; Kizilgün M; Kara F; Ardıc S
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):247-53. PubMed ID: 23893808
[TBL] [Abstract][Full Text] [Related]
34. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
Jia G; Erickson RW; Choy DF; Mosesova S; Wu LC; Solberg OD; Shikotra A; Carter R; Audusseau S; Hamid Q; Bradding P; Fahy JV; Woodruff PG; Harris JM; Arron JR;
J Allergy Clin Immunol; 2012 Sep; 130(3):647-654.e10. PubMed ID: 22857879
[TBL] [Abstract][Full Text] [Related]
35. High serum YKL-40 level in patients with COPD is related to hypoxemia and disease severity.
Gumus A; Kayhan S; Cinarka H; Kirbas A; Bulmus N; Yavuz A; Sahin U; Ozkaya S
Tohoku J Exp Med; 2013 Feb; 229(2):163-70. PubMed ID: 23364142
[TBL] [Abstract][Full Text] [Related]
36. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.
Lai T; Chen M; Deng Z; L Y; Wu D; Li D; Wu B
BMC Pulm Med; 2015 Jan; 15():1. PubMed ID: 25578181
[TBL] [Abstract][Full Text] [Related]
37. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
38. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
Otsuka K; Matsumoto H; Niimi A; Muro S; Ito I; Takeda T; Terada K; Yamaguchi M; Matsuoka H; Jinnai M; Oguma T; Nakaji H; Inoue H; Tajiri T; Iwata T; Chin K; Mishima M
Respiration; 2012; 83(6):507-19. PubMed ID: 21968467
[TBL] [Abstract][Full Text] [Related]
39. YKL-40 in Asthma and its correlation with different clinical parameters.
Saba M; Sharif MR; Akbari H; Nikoueinejad H; Ramazani Jolfaii M
Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):271-7. PubMed ID: 24659163
[TBL] [Abstract][Full Text] [Related]
40. Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers.
Ünal Çetin E; Kamiş F; Çetin AU; Beyazit Y; Kekilli M
Turk J Med Sci; 2021 Dec; 51(6):3038-3046. PubMed ID: 34579512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
